Logo image of PED

PEDEVCO CORP (PED) Stock Fundamental Analysis

NYSEARCA:PED - NYSE Arca - US70532Y3036 - Common Stock - Currency: USD

0.6469  +0.02 (+3.52%)

Premarket: 0.685 +0.04 (+5.89%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PED. PED was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. PED has only an average score on both its financial health and profitability. PED is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year PED was profitable.
In the past year PED had a positive cash flow from operations.
In multiple years PED reported negative net income over the last 5 years.
PED had a positive operating cash flow in each of the past 5 years.
PED Yearly Net Income VS EBIT VS OCF VS FCFPED Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

PED has a Return On Assets of 13.29%. This is amongst the best in the industry. PED outperforms 90.14% of its industry peers.
With a decent Return On Equity value of 14.69%, PED is doing good in the industry, outperforming 69.01% of the companies in the same industry.
PED's Return On Invested Capital of 2.98% is on the low side compared to the rest of the industry. PED is outperformed by 68.08% of its industry peers.
PED had an Average Return On Invested Capital over the past 3 years of 3.09%. This is significantly below the industry average of 25.88%.
Industry RankSector Rank
ROA 13.29%
ROE 14.69%
ROIC 2.98%
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
PED Yearly ROA, ROE, ROICPED Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

PED has a better Profit Margin (44.98%) than 92.02% of its industry peers.
PED's Operating Margin of 12.12% is in line compared to the rest of the industry. PED outperforms 41.78% of its industry peers.
PED's Gross Margin of 68.53% is fine compared to the rest of the industry. PED outperforms 76.06% of its industry peers.
PED's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.12%
PM (TTM) 44.98%
GM 68.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
PED Yearly Profit, Operating, Gross MarginsPED Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PED is destroying value.
Compared to 1 year ago, PED has more shares outstanding
PED has more shares outstanding than it did 5 years ago.
There is no outstanding debt for PED. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PED Yearly Shares OutstandingPED Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PED Yearly Total Debt VS Total AssetsPED Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.14 indicates that PED is not a great score, but indicates only limited risk for bankruptcy at the moment.
PED's Altman-Z score of 2.14 is fine compared to the rest of the industry. PED outperforms 72.30% of its industry peers.
PED has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.14
ROIC/WACC0.29
WACC10.36%
PED Yearly LT Debt VS Equity VS FCFPED Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

PED has a Current Ratio of 1.91. This is a normal value and indicates that PED is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PED (1.91) is better than 75.59% of its industry peers.
PED has a Quick Ratio of 1.91. This is a normal value and indicates that PED is financially healthy and should not expect problems in meeting its short term obligations.
PED's Quick ratio of 1.91 is fine compared to the rest of the industry. PED outperforms 77.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.91
PED Yearly Current Assets VS Current LiabilitesPED Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 185.71% over the past year.
The Revenue has grown by 28.49% in the past year. This is a very strong growth!
Measured over the past years, PED shows a very strong growth in Revenue. The Revenue has been growing by 24.98% on average per year.
EPS 1Y (TTM)185.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%376.79%
Revenue 1Y (TTM)28.49%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%56.87%

3.2 Future

PED is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -36.44% yearly.
The Revenue is expected to decrease by -0.26% on average over the next years.
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.14%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PED Yearly Revenue VS EstimatesPED Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
PED Yearly EPS VS EstimatesPED Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.23, which indicates a rather cheap valuation of PED.
Based on the Price/Earnings ratio, PED is valued cheaply inside the industry as 96.71% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.60. PED is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 10.67 indicates a reasonable valuation of PED.
Based on the Price/Forward Earnings ratio, PED is valued a bit cheaper than the industry average as 61.97% of the companies are valued more expensively.
PED's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.43.
Industry RankSector Rank
PE 3.23
Fwd PE 10.67
PED Price Earnings VS Forward Price EarningsPED Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

89.67% of the companies in the same industry are more expensive than PED, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.65
PED Per share dataPED EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PED's earnings are expected to decrease with -36.44% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-36.44%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PEDEVCO CORP

NYSEARCA:PED (5/20/2025, 8:26:24 PM)

Premarket: 0.685 +0.04 (+5.89%)

0.6469

+0.02 (+3.52%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-12 2025-08-12
Inst Owners2.95%
Inst Owner Change-9.05%
Ins Owners73.01%
Ins Owner Change4.62%
Market Cap59.09M
Analysts80
Price Target1.86 (187.53%)
Short Float %0.18%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)692.2%
Min EPS beat(2)104.85%
Max EPS beat(2)1279.56%
EPS beat(4)3
Avg EPS beat(4)348.7%
Min EPS beat(4)-0.99%
Max EPS beat(4)1279.56%
EPS beat(8)3
Avg EPS beat(8)155.29%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.92%
Min Revenue beat(2)1.14%
Max Revenue beat(2)12.69%
Revenue beat(4)4
Avg Revenue beat(4)13.78%
Min Revenue beat(4)1.14%
Max Revenue beat(4)23.63%
Revenue beat(8)6
Avg Revenue beat(8)7.68%
Revenue beat(12)8
Avg Revenue beat(12)5.37%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.39%
PT rev (3m)1.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.21%
Revenue NY rev (1m)-9.15%
Revenue NY rev (3m)-9.15%
Valuation
Industry RankSector Rank
PE 3.23
Fwd PE 10.67
P/S 1.49
P/FCF N/A
P/OCF 4.63
P/B 0.49
P/tB 0.49
EV/EBITDA 2.65
EPS(TTM)0.2
EY30.92%
EPS(NY)0.06
Fwd EY9.37%
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)0.14
OCFY21.61%
SpS0.43
BVpS1.33
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 13.29%
ROE 14.69%
ROCE 3.78%
ROIC 2.98%
ROICexc 3.08%
ROICexgc 3.08%
OM 12.12%
PM (TTM) 44.98%
GM 68.53%
FCFM N/A
ROA(3y)5.71%
ROA(5y)-5.05%
ROE(3y)6.44%
ROE(5y)-5.07%
ROIC(3y)3.09%
ROIC(5y)N/A
ROICexc(3y)3.72%
ROICexc(5y)N/A
ROICexgc(3y)3.72%
ROICexgc(5y)N/A
ROCE(3y)3.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.09%
GM growth 5Y7.61%
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 174.84%
Cap/Sales 70.86%
Interest Coverage 250
Cash Conversion 61.31%
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.91
Altman-Z 2.14
F-Score7
WACC10.36%
ROIC/WACC0.29
Cap/Depr(3y)201.19%
Cap/Depr(5y)159.31%
Cap/Sales(3y)75.11%
Cap/Sales(5y)87.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%376.79%
EPS Next Y-69.7%
EPS Next 2Y-36.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.49%
Revenue growth 3Y35.61%
Revenue growth 5Y24.98%
Sales Q2Q%56.87%
Revenue Next Year-6.14%
Revenue Next 2Y-0.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year208.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.63%
OCF growth 3Y28.83%
OCF growth 5Y50.2%